Veterinary Biomarkers Market Trends

Veterinary Biomarkers Market Trends

The rising incidence of chronic diseases such as cardiovascular diseases and cancer in animals is a key driver of the market growth. The high prevalence of these diseases necessitates the adoption of biomarkers for early diagnosis, monitoring, and treatment evaluation. The adoption of biomarkers helps veterinarians provide more accurate and timely care, enhancing animal health and welfare.
 

• Chronic kidney disease (CKD) is increasingly common among aging cats, leading to rising demand for diagnostic tests, treatments, and management strategies tailored to feline CKD. Cats exhibit the highest prevalence of renal diseases in veterinary medicine compared to dogs, horses, and cows.
   
• For instance, data from the American Veterinary Medical Association in 2021 indicated CKD prevalence in cats ranging from 2% to 20%, escalating to 30% to 80% among those over 10 to 15 years old. This growing prevalence and emphasis on early detection are expected to drive market growth significantly.
   

Furthermore, increased spending on animal healthcare, rising adoption of pet insurance, advancements in diagnostic technologies, government support, and strategic expansions by key industry players are additional factors driving demand for diagnostic veterinary services.